BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29512108)

  • 1. Direct Conversion of Human Pluripotent Stem Cells to Osteoblasts With a Small Molecule.
    Kang H; Shih YV; Varghese S
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():1F.21.1-1F.21.6. PubMed ID: 29512108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule-driven direct conversion of human pluripotent stem cells into functional osteoblasts.
    Kang H; Shih YR; Nakasaki M; Kabra H; Varghese S
    Sci Adv; 2016 Aug; 2(8):e1600691. PubMed ID: 27602403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells.
    Mathapati S; Siller R; Impellizzeri AA; Lycke M; Vegheim K; Almaas R; Sullivan GJ
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():1G.6.1-1G.6.18. PubMed ID: 27532814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro culture and directed osteogenic differentiation of human pluripotent stem cells on peptides-decorated two-dimensional microenvironment.
    Wang M; Deng Y; Zhou P; Luo Z; Li Q; Xie B; Zhang X; Chen T; Pei D; Tang Z; Wei S
    ACS Appl Mater Interfaces; 2015 Mar; 7(8):4560-72. PubMed ID: 25671246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors.
    Lippmann ES; Estevez-Silva MC; Ashton RS
    Stem Cells; 2014 Apr; 32(4):1032-42. PubMed ID: 24357014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
    Meng G; Liu S; Rancourt DE
    Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells.
    Shimojo D; Onodera K; Doi-Torii Y; Ishihara Y; Hattori C; Miwa Y; Tanaka S; Okada R; Ohyama M; Shoji M; Nakanishi A; Doyu M; Okano H; Okada Y
    Mol Brain; 2015 Dec; 8(1):79. PubMed ID: 26626025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in β-cell differentiation of pluripotent stem cells induced by small and large molecules.
    Kumar SS; Alarfaj AA; Munusamy MA; Singh AJ; Peng IC; Priya SP; Hamat RA; Higuchi A
    Int J Mol Sci; 2014 Dec; 15(12):23418-47. PubMed ID: 25526563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise differentiation of pluripotent stem cells into osteoblasts using four small molecules under serum-free and feeder-free conditions.
    Kanke K; Masaki H; Saito T; Komiyama Y; Hojo H; Nakauchi H; Lichtler AC; Takato T; Chung UI; Ohba S
    Stem Cell Reports; 2014 Jun; 2(6):751-60. PubMed ID: 24936463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture and differentiation of osteoblasts on coral scaffold from human bone marrow mesenchymal stem cells.
    Tran CT; Gargiulo C; Thao HD; Tuan HM; Filgueira L; Michael Strong D
    Cell Tissue Bank; 2011 Nov; 12(4):247-61. PubMed ID: 20703817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effective differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules.
    Tasnim F; Phan D; Toh YC; Yu H
    Biomaterials; 2015 Nov; 70():115-25. PubMed ID: 26310107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically Defined Neural Conversion of Human Pluripotent Stem Cells.
    Chen Y; Tristan CA; Mallanna SK; Ormanoglu P; Titus S; Simeonov A; Singeç I
    Methods Mol Biol; 2019; 1919():59-72. PubMed ID: 30656621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Epithelial Cell Populations from Human Pluripotent Stem Cells Using a Small-Molecule Inhibitor of Src Family Kinases.
    Selekman JA; Lian X; Palecek SP
    Methods Mol Biol; 2016; 1307():319-27. PubMed ID: 24500899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of Pericytes from Human Pluripotent Stem Cells.
    Dar A; Itskovitz-Eldor J
    Methods Mol Biol; 2021; 2235():119-125. PubMed ID: 33576973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha.
    Ben-David U; Cowell IG; Austin CA; Benvenisty N
    Stem Cells; 2015 Mar; 33(3):1013-9. PubMed ID: 25377277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells.
    Siller R; Greenhough S; Naumovska E; Sullivan GJ
    Stem Cell Reports; 2015 May; 4(5):939-52. PubMed ID: 25937370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells.
    Siller R; Sullivan GJ
    Curr Protoc Stem Cell Biol; 2017 Nov; 43():1G.7.1-1G.7.23. PubMed ID: 29140570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.
    Kropp EM; Oleson BJ; Broniowska KA; Bhattacharya S; Chadwick AC; Diers AR; Hu Q; Sahoo D; Hogg N; Boheler KR; Corbett JA; Gundry RL
    Stem Cells Transl Med; 2015 May; 4(5):483-93. PubMed ID: 25834119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.